Dermal filler brand Revanesse, owned by PROLLENIUM, hosted the Revanesse Redefine Conference 2026.
The conference welcomed more than 130 aesthetic practitioners to London’s Ham Yard Hotel on February 2, 2026, for a day of advanced clinical education, live demonstrations and peer discussion, according to the company.
Led by Canadian plastic surgeon Mr Arthur Swift, sessions highlighted anatomy-based injection techniques, including management of complex cases such as volume restoration in GLP-1 patients, shares the company. Combination therapies were also explored, with dermatologist Dr Patricia Ogilvie presenting multimodal protocols integrating HA fillers and laser technologies for rosacea and other complex skin concerns, according to Revanesse.
Aesthetic practitioner Dr Johanna Ward delivered a live demonstration on lip and perioral treatments, emphasising proportion, structural support and natural enhancement. The conference was hosted by aesthetic practitioner Dr Marcus Mehta, with additional insights from nurse prescriber Sharon Bennett during panel discussions.
Dr Mehta commented, “The Revanesse Redefine Conference was one of the UK’s most exciting aesthetic education events. Featuring global faculty, inspiring lectures and live injection demonstrations, it captured the direction of our rapidly advancing specialty.”